Funded Tech Companies

PharmatrophiX

Wondering who invested in PharmatrophiX? Private investors and Dolby Family Ventures joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Company Name
PharmatrophiX
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
2300 Wells Fargo Capitol Center
Raleigh, NC 27601
USA
Phone
Undisclosed
Email Address
Not Recorded

Company Background Information

Overview
PharmatrophiX is a biotech working on drugs that prevent neurodegenerative disease. Founded by Stanford researcher Frank Longo, PharmatrophiX is developing a class of drugs that mimic the activity of proteins called neurotrophins, which aid in the development, health and survival of neurons.
Profile
PharmatrophiX LinkedIn Company Profile
Social Media
PharmatrophiX Company Twitter Account
Company News
PharmatrophiX News
Facebook
PharmatrophiX on Facebook
YouTube
PharmatrophiX on YouTube
Last Transaction
11/23/2015

Financing History

Date
Type
Amount
Debt
$10,300,000
Venture Equity
$5,500,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Anne Longo
  Anne Longo LinkedIn Profile  Anne Longo Twitter Account  Anne Longo News  Anne Longo on Facebook
Chief Financial Officer
John Autrey
  John Autrey LinkedIn Profile  John Autrey Twitter Account  John Autrey News  John Autrey on Facebook


Company Investors

  • Dolby Family Ventures (David Dolby)

 

 

 

Browse more funded tech companies:

PharmAthene | Pharmbid

 

Share this article

 


About Our VC Transaction Database

Our data comes from VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary